Di Mauro, A.; Berretta, M.; Santorsola, M.; Ferrara, G.; Picone, C.; Savarese, G.; Ottaiano, A.
Towards Post-Genomic Oncology: Embracing Cancer Complexity via Artificial Intelligence, Multi-Targeted Therapeutics, Drug Repurposing, and Innovative Study Designs. Int. J. Mol. Sci. 2025, 26, 7723.
https://doi.org/10.3390/ijms26167723
AMA Style
Di Mauro A, Berretta M, Santorsola M, Ferrara G, Picone C, Savarese G, Ottaiano A.
Towards Post-Genomic Oncology: Embracing Cancer Complexity via Artificial Intelligence, Multi-Targeted Therapeutics, Drug Repurposing, and Innovative Study Designs. International Journal of Molecular Sciences. 2025; 26(16):7723.
https://doi.org/10.3390/ijms26167723
Chicago/Turabian Style
Di Mauro, Annabella, Massimiliano Berretta, Mariachiara Santorsola, Gerardo Ferrara, Carmine Picone, Giovanni Savarese, and Alessandro Ottaiano.
2025. "Towards Post-Genomic Oncology: Embracing Cancer Complexity via Artificial Intelligence, Multi-Targeted Therapeutics, Drug Repurposing, and Innovative Study Designs" International Journal of Molecular Sciences 26, no. 16: 7723.
https://doi.org/10.3390/ijms26167723
APA Style
Di Mauro, A., Berretta, M., Santorsola, M., Ferrara, G., Picone, C., Savarese, G., & Ottaiano, A.
(2025). Towards Post-Genomic Oncology: Embracing Cancer Complexity via Artificial Intelligence, Multi-Targeted Therapeutics, Drug Repurposing, and Innovative Study Designs. International Journal of Molecular Sciences, 26(16), 7723.
https://doi.org/10.3390/ijms26167723
